Bartlett & Co’s Omnicell OMCL Stock Holding History

Bartlett & Co’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9	Closed	-$1K	–	1157
2022 Q3	$1K	Sell	9 -14	-61%	-$1.47K	﹤0.01%	1119
2022 Q2	$3K	Buy	+23	New	+$2.64K	﹤0.01%	1127
2021 Q1	–	Sell	-26	Closed	-$3K	–	1137
2020 Q4	$3K	Buy	+26	New	+$2.55K	﹤0.01%	861

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bartlett & Co's OMCL Position: Q4 2022 in Review

Bartlett & Co sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 9 shares — an estimated $1K sold.

Bartlett & Co first reported a position in OMCL in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

Bartlett & Co reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
Bartlett & Co sold 9 Omnicell shares in Q4 2022, an estimated $1K.
Bartlett & Co first reported a position in Omnicell in Q4 2020 and held it in 3 quarters.
Bartlett & Co's Omnicell position peaked at $3K in Q2 2022.
329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Bartlett & Co's 13F filing for Q4 2022, filed 4 Jan 2023.